FindTrial
Sign In

Effect of IVIg on chronic inflammatory demyelinating radiculopathy: a case records based study

Effect of short course of IVIg on chronic inflammatory demyelinating radiculopathy: a case records based study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900021794
Enrollment
Unknown
Registered
2019-03-10
Start date
2019-03-10
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic inflammatory demyelinating radiculopathy

Interventions

Two groups:immunoglobulin combined with hormones versus other immunosuppressive agents

Sponsors

Department of Neurology, People's Hospital of Wuhan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 80 Years

Inclusion criteria

Inclusion criteria: In line with the European Union of Neurology / Peripheral Neurological Association published a joint recommendation for the diagnosis and treatment of CIDP in the European Journal of Neurology

Exclusion criteria

Exclusion criteria: Exclude chronic multiple peripheral neuropathy caused by various causes, such as differentiation of peripheral neuropathy caused by metabolic, drug, toxic, connective tissue diseases, etc., in adolescents, and various hereditary demyelinating peripheral neuropathy, Such as the identification of Charcot-Marie-Tooth disease (CMT)

Design outcomes

Primary

MeasureTime frame
EMG;—

Countries

China

Contacts

Public ContactLu Zuneng

Renmin Hospital of Wuhan University

luzuneng1964@163.com+86 13995672166

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026